The Risk of Hepatocellular Carcinoma in Patients with Previous Malignancy

REFERENCES

• Parkin D. M., Bray F., Ferlay J., Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94: 153–156
   PubMed Web of Science ®Google Scholar
• El-Serag H. B., Mason A. C. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340: 745–750
   PubMed Web of Science ®Google Scholar
• El-Serag H. B., Davila J. A., Petersen N. J., McGlynn K. A. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 2003; 0139: 817–823
   Google Scholar
• El-Serag H. B., Mason A. C., Key C. Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States. Hepatol 2001; 33: 62–65
   PubMed Web of Science ®Google Scholar
• Chen C. J., Yu M. W., Liaw Y. F. Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol 1997; 12: S294–S308
   PubMed Web of Science ®Google Scholar
• Neugut A. I., Robinson E., Nieves J., Murray T., Tsai W. Y. Poor survival of treatment-related acute nonlymphocytic leukemia. Jama 1990; 264: 1006–1008
   PubMed Web of Science ®Google Scholar
• http:/seer.cancer.gov/about/ A. S. C.
   Google Scholar
• NE B., NE D. Statistical Methods in Cancer Research: Vol II. The Design and Analysis of Cohort Studies. International Agency for Research on Cancer, Lyon 1987
   Google Scholar
• Salmon-Ceron D., Lewden C., Morlat P., Bevilacqua S., Jougla E., Bonnet F., Heripret L., Costagliola D., May T., Chene G. Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol. J Hepatol 2005; 42: 799–805
   PubMed Web of Science ®Google Scholar
• Boffetta P., Hashibe M. Alcohol and cancer. Lancet Oncol 2006; 7: 149–156
   PubMed Web of Science ®Google Scholar
• Homann N., Stickel F., Konig I. R., Jacobs A., Junghanns K., Benesova M., Schuppan D., Himsel S., Zuber-Jerger I., Hellerbrand C., Ludwig D., Caselmann W. H., Seitz H. K. Alcohol dehydrogenase 1C*1 allele is a genetic marker for alcohol-associated cancer in heavy drinkers. Int J Cancer 2006; 118: 1998–2002
   PubMed Web of Science ®Google Scholar
• Miyamoto Y., Shimada K., Sakaguchi Y., Miyamoto M. Cisplatin (cddp)-induced acute toxicity in an experimental model of hepatic fibrosis. J Toxicol Sci 2007; 32: 311–319
   PubMedGoogle Scholar
• Chien Y. C., Chen J. Y., Liu M. Y., Yang H. I., Hsu M. M., Chen C. J., Yang C. S. Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N Engl J Med 2001; 345: 1877–1882
   PubMed Web of Science ®Google Scholar
• Scinicariello F., Sato T., Lee C. S., Hsu H. C., Chan T. S., Tyring S. K. Detection of human papillomavirus in primary hepatocellular carcinoma. Anticancer Res 1992; 12: 763–766
   PubMed Web of Science ®Google Scholar
• Cannon M. J., Dollard S. C., Smith D. K., Klein R. S., Schuman P., Rich J. D., Vlahov D., Pellett P. E. Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection. N Engl J Med 2001; 344: 637–643
   PubMed Web of Science ®Google Scholar
• Martin J. N., Ganem D. E., Osmond D. H., Page-Shafer K. A., Macrae D., Kedes D. H. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med 1998; 338: 948–954
   PubMed Web of Science ®Google Scholar
• Strader D. B. Coinfection with HIV hepatitis C virus in injection drug users and minority populations. Clin Infect Dis 2005; 41(Suppl 1)S7–S13
   PubMedGoogle Scholar
• Mele A., Pulsoni A., Bianco E., Musto P., Szklo A., Sanpaolo M. G., Iannitto E., De Renzo A., Martino B., Liso V., Andrizzi C., Pusterla S., Dore F., Maresca M., Rapicetta M., Marcucci F., Mandelli F., Franceschi S. Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study. Blood 2003; 102: 996–969
   PubMed Web of Science ®Google Scholar
• Hausfater P., Cacoub P., Rosenthal E., Bernard N., Loustaud-Ratti V., Le Lostec Z., Laurichesse H., Turpin F., Ouzan D., Grasset D., Perrone C., Cabrol M. P., Piette J. C. Hepatitis C virus infection and lymphoproliferative diseases in France: a national study. The GERMIVIC Group. Am J Hematol 2000; 64: 107–111
   PubMed Web of Science ®Google Scholar
• Giordano T. P., Henderson L., Landgren O., Chiao E. Y., Kramer J. R., El-Serag H., Engels E. A. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA 2007; 297: 2010–2017
   PubMed Web of Science ®Google Scholar
• Smedile A., Bugianesi E. Steatosis and hepatocellular carcinoma risk. Eur Rev Med Pharmacol Sci 2005; 9: 291–293
   PubMedGoogle Scholar
• Marrero J. A., Fontana R. J., Fu S., Conjeevaram H. S., Su G. L., Lok A. S. Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol 2005; 42: 218–224
   PubMed Web of Science ®Google Scholar
• McGinnis K. A., Fultz S. L., Skanderson M., Conigliaro J., Bryant K., Justice A. C. Hepatocellular carcinoma and non-Hodgkin's lymphoma: the roles of HIV, hepatitis C infection, and alcohol abuse. J Clin Oncol 2006; 24: 5005–5009
   PubMed Web of Science ®Google Scholar
• Curtis R., Freedman D., Ron E., Ries L., Hacker D., Edwards B., Tucker M., Eds J. F. J. New malignancies among cancer survivors. NIH, Bethesda 2006, 05-5302
   Google Scholar